Peter DeMuth

Direttore Tecnico/Scientifico/R&S presso ELICIO THERAPEUTICS, INC.

Patrimonio netto: - $ in data 31/05/2024

38 anni

Health Technology

Finance

Consumer Services

Posizioni attive di Peter DeMuth

Società	Posizione	Inizio	Fine
ELICIO THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	01/01/2022	-

Società	Posizione	Inizio	Fine
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Direttore Tecnico/Scientifico/R&S	01/08/2017	01/06/2023

Massachusetts Institute of Technology	Doctorate Degree
University of Maryland	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ELICIO THERAPEUTICS, INC.	Health Technology

Aziende private	1
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Health Technology